Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kelch domain-containing protein 7A (KLHDC7A) is a member of the Kelch domain-containing protein family, a group of proteins that typically function as adaptors in protein–protein interactions, often facilitating the ubiquitination and degradation of substrates via cullin–RING E3 ubiquitin ligase complexes[3][4]. KLHDC7A is predicted to localize to nuclear speckles and possibly membranes, with expression seen in multiple tissues, especially the kidney[1][4]. Although direct functional assignment is limited, KLHDC7A has been implicated in vascular disease through genetic association studies (notably diabetic retinopathy), in tissue remodeling diseases (such as Dupuytren’s contracture), and as a possible biomarker for intracranial aneurysm[2]. The precise biological mechanisms remain unclear, but it is believed KLHDC7A may play roles in regulating vascular integrity, extracellular matrix signaling, and cell differentiation/proliferation through its putative adaptor activity in ubiquitin-mediated protein degradation[2][4]. No currently approved drugs target KLHDC7A directly, and its status as a direct therapeutic target remains unproven.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch domain-containing protein 7A (KLHDC7A).